Will Aethlon Medical stock go up?

According to Danelfin AI, Aethlon Medical has today an AI Score of 1/10 (Strong Sell rating), because its probability of beating the market in 3 months (37.18%) is -13.64% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Aethlon Medical stock?

The Aethlon Medical target price is $0.71 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Aethlon Medical stock right now?

Aethlon Medical has today a Strong Sell rating (AI Score 1/10), according to Danelfin AI. Its probability of beating the market in 3 months (37.18%) is -13.64% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Aethlon Medical stock is a good buy .

Is Aethlon Medical undervalued right now?

Based on analysts, the average price target downside for Aethlon Medical is 0.00% (1Y). According to Danelfin AI, Aethlon Medical has today an AI Score of 1/10 (Strong Sell Rating).

What was the price range of Aethlon Medical stock over the past 12 months?

The Aethlon Medical stock price range over the past 12 months has been $0.71 - $21.9.

What is going on with Aethlon Medical stock in the last 3 months?

The Aethlon Medical stock performance in the last quarter has been -66.92%.

Does Aethlon Medical offer dividend payments?

No, Aethlon Medical does not currently pay dividends.

What is the current market capitalization of Aethlon Medical?

Aethlon Medical's market cap is $1.68M, as of 2026-07-03 08:00.

Aethlon Medical Inc (AEMD) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

AEMD AI-Powered Stock Analysis

AI Score Explanation

AI Score

Strong Sell

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, Aethlon Medical Inc today receives an AI Score of 1/10, which translates to a Strong Sell rating. The stock has a 37% probability of outperforming the market in the next 3 months, which is 14% lower than the average probability of any stock (51%). This low probability is driven by a mix of negative and positive signals. The top detractors include the Chart Pattern (252d) (impact: -1.92%), the Health Care Equipment & Supplies industry (impact: -1.75%), and the Chart Pattern (504d) (impact: -1.23%). Additionally, Maximum Volatility (impact: -1.13%) is in the top 10%, indicating extreme price swings, while Basic EPS Consolidated (impact: -1.12%) is in the bottom 10% with a value of -10.61, reflecting poor profitability. On the positive side, the ATR (14d Volatility) (impact: +0.64%) is in the bottom 20%, suggesting low short-term volatility, and Earnings Countdown (impact: +0.51%) is in the top 50%, with earnings already reported 16 days ago. Notable data points include Institutional Ownership at 6.46% (bottom 20%), indicating low confidence from large investors, and Analyst Lowest Price Upside at -93.15% (bottom 10%), reflecting a very bearish analyst outlook. The Fear & Greed Index at 31 signals extreme fear in the market, which often correlates with negative sentiment. The Short Float (%) at 8.25% (top 20%) suggests elevated bearish bets against the stock. Overall, the combination of poor technical patterns, weak fundamentals, high volatility, and negative sentiment heavily outweighs the few positive signals, resulting in a Strong Sell rating and a low probability of outperforming the market.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Sentiment-4.30%
How analysts and the market view the stock
Momentum-3.94%
Direction and strength of recent price movements
Volatility-1.94%
How much the stock price tends to fluctuate
Growth-1.12%
Expected pace of revenue and earnings expansion
Valuation-1.05%
How the stock is priced relative to its fundamentals
Size & Liquidity-0.65%
Company size and trading liquidity
Earnings Quality-0.36%
Stability and reliability of reported earnings
Financial Strength-0.28%
Balance sheet strength and financial resilience

AEMD probability advantage of beating the market (3M):

-13.64%

AI Score

Strong Sell

Aethlon Medical (AEMD) has an AI Score of 1/10 (Strong Sell) because, according to an overall analysis, it has a probability advantage of -13.64% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of AEMD (37.18%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
AEMD probability advantage of beating the market (3M)-13.64%
AEMD probability of beating the market (3M)37.18%

AEMD probability advantage of beating the market (3M): -13.64%

The AI-powered overall analysis of Aethlon Medical (AEMD) is based on the 28 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of AEMD:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Technical	Chart Pattern (252d)	figure_8	N/A	-1.92%
Sentiment	Industry (GICS)	Health Care Equipment & Supplies	N/A	-1.75%
Technical	Chart Pattern (504d)	figure_12	N/A	-1.23%
Technical	Maximum Volatility	23.69%		-1.13%
Fundamental	Basic EPS Consolidated	-10.61	N/A	-1.12%
Sentiment	Institutional Ownership	6.46%		-0.95%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-0.83%
Sentiment	Analyst Lowest Price Upside	-0.93%	N/A	-0.67%
Technical	Chart Pattern (120d)	figure_19	N/A	-0.67%
Fundamental	Beginning Cash (Millions)	5.6		-0.65%
Technical	Upgrade to unlock			+0.64%
Technical	Upgrade to unlock			-0.56%
Sentiment	Upgrade to unlock			+0.51%
Fundamental	Upgrade to unlock			-0.50%
Sentiment	Upgrade to unlock			-0.49%

Rest of Alpha Signals: -2.31%

AEMD probability advantage of beating the market (3M)Total:-13.64%
AEMD AI Score

Significant changes Vs previous day

AEMD Short Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$0.71
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro)
Take Profit:$XXXXXPro (XXXXX
Pro
)

AEMD Proven Sell Signal & Price Forecast

This is the price chart for AEMD from January 2, 2026 until today. The chart indicates, in red, the 113 days when the stock received a Sell/Strong Sell rating (sell signals, AI Score 1 to 3).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Sell signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Sell signals

Forecast:

1 Month
3 Months
6 Months
1 Year

AEMD Average Past Performance & Loss Rate

Three months after its 1369 Sell signals since July 2026, AEMD had an average performance of xxxxxxx and a xxxxxx Loss rate (negative performance).

1369 Past AEMD Sell Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-40.59%
Average Alpha				-55.09%
Loss Rate (% Negative Perf.)				83.85%
% Negative Alpha				88.75%

AEMD Frequently Asked Questions

Will Aethlon Medical stock go up?
According to Danelfin AI, Aethlon Medical has today an AI Score of 1/10 (Strong Sell rating), because its probability of beating the market in 3 months (37.18%) is -13.64% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Aethlon Medical stock?
Is it a good time to buy, sell, or hold Aethlon Medical stock right now?
Is Aethlon Medical undervalued right now?
What was the price range of Aethlon Medical stock over the past 12 months?
What is going on with Aethlon Medical stock in the last 3 months?
Does Aethlon Medical offer dividend payments?
What is the current market capitalization of Aethlon Medical?

Aethlon Medical Inc Company Profile

Aethlon Medical, Inc. stands as a medical therapy enterprise concentrating on the creation of solutions for cancer and severe infectious ailments prevalent within the United States. Critical to its innovative portfolio is the Aethlon Hemopurifier, an immunotherapeutic instrument currently in clinical trials geared towards extracting tumor-released exosomes and hazardous viruses from the patient's bloodstream. Officially taking root in 1999, this company has since anchored its operations in San Diego California.

Sector:
Country:United States
Industry:
Address:11555 Sorrento Valley Road, Suite 203, San Diego
Employees:9
Website:aethlonmedical.com

Pros

Proprietary technology in therapeutic apheresis for pathogen removal

Addressing unmet medical needs in severe viral infections and oncology

Potential for broad application across multiple disease indications

High switching costs for medical devices integrated into hospital protocols

Scalability of manufacturing through contract development and manufacturing organizations

Cons

Extensive regulatory approval process for novel medical devices

High capital expenditure required for clinical trials and product development

Uncertainty of reimbursement coverage for new and specialized therapies

Competition from alternative pharmaceutical and device-based treatments

Reliance on successful clinical trial results for commercialization

Company	AI Score	Compare
HAEHaemonetics Corp
CTSOCytosorbents Corp
APYXApyx Medical Inc
INFUInfuSystem Holdings Inc
ITOCiTonic Holdings Ltd

Company	AI Score	Compare
HAEHaemonetics Corp
CTSOCytosorbents Corp
APYXApyx Medical Inc
INFUInfuSystem Holdings Inc
ITOCiTonic Holdings Ltd

AEMD Stock AI Analysis High Risk